The DOI matches its Crossref record; 141 of the 146 references it cites were found in a registry or an index, and 5 are not checked yet.
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Open accessAbstract
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly extended to become a global sanitary and economic emergency. Its etiological agent is the coronavirus SARS-CoV-2. COVID-19 presents a wide spectrum of clinical manifestations, which ranges from an asymptomatic infection to a severe pneumonia accompanied by multisystemic failure that can lead to a patient's death. The immune response to SARS-CoV-2 is known to involve all the components of the immune system that together appear responsible for viral elimination and recovery from the infection. Nonetheless, such immune responses are implicated in the disease's progression to a more severe and lethal process. This review describes the general aspects of both COVID-19 and its etiological agent SARS-CoV-2, stressing the similarities with other severe coronavirus infections, such as SARS and MERS, but more importantly, pointing toward the evidence supporting the hypothesis that the clinical spectrum of COVID-19 is a consequence of the corresponding variable spectrum of the immune responses to the virus. The critical point where progression of the disease ensues appears to center on loss of the immune regulation between protective and altered responses due to exacerbation of the inflammatory components. Finally, it appears possible to delineate certain major challenges deserving of exhaustive investigation to further understand COVID-19 immunopathogenesis, thus helping to design more effective diagnostic, therapeutic, and prophylactic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among them, IL-6 is a major player in chronic inflammatory diseases, autoimmune diseases, cancer and cytokine storm (1, 3, 10–26).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with the notion that severe COVID-19 is a cytokine storm syndrome (12–17, 336), the severity of COVID-19 is associated with an increased level of inflammatory cytokines, such as IL-6, granulocyte macrophage colony-stimulating factor (GM-CSF) and TNFα (333, 337).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ARDS in COVID-19 is considered the result of cytokine storm (12–17), resembling the disease caused by SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV) (335).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 162
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Cited by
Sorted by citations
Items 401–500 of 740
Zarkesh, M., Sanoie, M., Heydarzadeh, S., Abooshahab, R., Daneshafrooz, A., Hosseinpanah, F., & Hedayati, M. (2024) · Intern J Endocrinol Metab · doi:10.5812/ijem-146857 · Cited by 4
Saldaña, A. S., Gil-Sánchez, A., Quirant‐Sánchez, B., Nogueras, L., Peralta, S., Solana, M. J., González‐Mingot, C., Gallego, Y., Quibus, L., Ramo-Tello, C. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092509 · Cited by 4
Николаевна, Г. С., Rybalko, A. S., Александрович, К. Н., Zolotova, E. A., Переходов, С. Н., & Chaus, N. I. (2022) · Medical alphabet · doi:10.33667/2078-5631-2022-23-15-19 · Cited by 4
Jergović, M., Watanabe, M., Bhat, R., Coplen, C. P., Sonar, S. A., Wong, R., Castaneda, Y., Davidson, L., Kala, M., Wilson, R. C., et al. (2023) · GeroScience · doi:10.1007/s11357-022-00724-y · Cited by 5
Pal, A., Roongta, R., Mondal, S., Sinha, D., Sinhamahapatra, P., Ghosh, A., & Chattopadhyay, A. (2023) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2022.03.005 · Cited by 4
Lu, T., Man, Q., Yu, X., Xia, S., Lu, L., Jiang, S., & Xiong, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1157892 · Cited by 4
Nanda, R., Gupta, P., Giri, A. K., Patel, S., Shah, S., & Mohapatra, E. (2023) · Cureus · doi:10.7759/cureus.40543 · Cited by 4
Silva, E. E., Moioffer, S. J., Hassert, M., Berton, R. R., Smith, M., van de Wall, S., Meyerholz, D. K., Griffith, T. S., Harty, J. T., & Badovinac, V. P. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300434 · Cited by 4
Rashid, Z., Fatima, A., Khan, A., Matthew, J., Yousaf, M. Z., Nadeem, N., Hasan, T. N., Rehman, M. U., Naqvi, S. S., & Khan, S. J. (2024) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.18189 · Cited by 4
Armstrong, A., Tang, Y., Mukherjee, N. Z., Zhang, N., & Huang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448201 · Cited by 4
Alston, B., Maphutha, J., Ackron, J., Kok, A.-M., & Lall, N. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.05.053 · Cited by 4
Yaseen, A. R., Suleman, M., Afzal, M., Usama, H., Ashfaq, W., Firyal, S., Arif, A., Latif, A., Ali, A., & Qadri, A. S. (2025) · The Nucleus · doi:10.1007/s13237-025-00587-6 · Cited by 4
Александровна, Р. А., Попова, В. В., Lyovina, A. V., Krasnov, A. A., & Викторович, П. С. (2021) · Immunologiya · doi:10.33029/0206-4952-2021-42-2-148-158 · Cited by 4
Genetics and Vaccine Development for SARS-CoV2 in the Era of Personalized Medicine
Tafanidou, E. K., & Gkentzi, D. (2021) · Infectious Disorders - Drug Targets · doi:10.2174/1871526521666210720124950 · Cited by 4
Zhou, B., Li, S., Ye, J., Liu, Y., Hu, L., Tang, Y., Wu, Z., & Zhang, P. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108254 · Cited by 4
Immunological Biomarkers in Blood to Monitor the Course and Therapeutic Outcomes of COVID-19
Wieland, E. (2021) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000945 · Cited by 4
Ciórraga, E. H. (2021) · REVISTA ESPAÑOLA DE COMUNICACIÓN EN SALUD · doi:10.20318/recs.2021.5750 · Cited by 4
Gardner, R. L., Haskell, J., Jenkins, B. C., Capizzo, L., Cooper, E., & Morphis, B. (2022) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2021.0429 · Cited by 3
Mukherjee, S., Ray, S. K., Kotnis, A. L., & Kanwar, J. R. (2022) · Current Cardiology Reviews · doi:10.2174/1573403x18666220222144002 · Cited by 4
Kang, J., Kang, J., Seo, W. J., Park, S. H., Kang, H. K., Park, H. K., Song, J. E., Kwak, Y. G., Chang, J., Kim, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.914098 · Cited by 4
SARS-CoV-2 viral shedding and susceptibility: perspectives on gender and asymptomatic patients
Rahman, E. N. S. E. A., Fandi, A. A., Irekeola, A. A., Musa, N., Furusawa, G., & Yean, C. Y. (2022) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.14721 · Cited by 4
Persistent Coronavirus Disease 2019 Headache Relieved with Sphenopalatine Ganglion Block
Levin, D., Acquadro, M. A., Cerasuolo, J., & Gerges, F. J. (2022) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2022.21318 · Cited by 4
Saraswathi, N. T., Jeevanandam, J., Esackimuthu, P., Palanisamy, A., & Raghavendran, S. (2022) · Current Computer - Aided Drug Design · doi:10.2174/1573409918666220914092145 · Cited by 4
Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?
Indu, D. P., L, K. Y. M., & Chetana, G. S. (2023) · Cureus · doi:10.7759/cureus.36734 · Cited by 4
Caballero-Suárez, N. P., Barrientos-Casarrubias, V., Gutiérrez-Velilla, E., Avilés, L. M. G., Pérez-López, L., la Barrera, C. A., Ávila‐Ríos, S., & Mora-Gallegos, J. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s434448 · Cited by 4
Wu, Y., Li, Y., Zhou, Y., Bai, X., & Liu, Y. (2024) · Autoimmunity · doi:10.1080/08916934.2024.2304826 · Cited by 4
The efficacy and safety of Xuebijing injection for corona virus disease 2019
Fu, J., Wu, L., Ma, Y., & Liang, Q. (2020) · Medicine · doi:10.1097/md.0000000000023401 · Cited by 4
Föll, S., Lison, A., Maritsch, M., Klingberg, K., Lehmann, V. F., Züger, T., Srivastava, D., Jegerlehner, S. N., Feuerriegel, S., Fleisch, E., et al. (2022) · JMIR Formative Research · doi:10.2196/35717 · Cited by 5
Fox, R. J., Symmons, S. M., Brún, A. D., Joyce, D., Muldoon, E. G., McGinty, T., O’Reilly, K. M., O’Connor, E., & McAuliffe, É. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051408 · Cited by 4
Lemsara, A., Chan, A., Wolff, D., Marschollek, M., Li, Y., & Dieterich, C. (2022) · medRxiv · doi:10.1101/2022.10.21.22280983 · Cited by 4
Mikheeva, E. V., Aulova, K. S., Nevinsky, G. A., & Timofeeva, A. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010100 · Cited by 7
Aslan, M., & Levent, A. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345060 · Cited by 3
The Potential Anti-Inflammatory Effects of Zerumbone in COVID-19 Patients
Dehghan, R., Soheilifar, M. H., Jalilian, F. A., Najafi, R., & Amini, R. (2021) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v13i4.7217 · Cited by 3
Leache, L., Gutiérrez‐Valencia, M., Enguita‐Germán, M., Librero, J., Gorricho, J., Jericó, C. R., & García‐Erce, J. A. (2022) · Vox Sanguinis · doi:10.1111/vox.13334 · Cited by 3
Anti‐inflammatory effects of sodium‐glucose cotransporter‐2 inhibitors in COVID‐19
Yaribeygi, H., Maleki, M., Atkin, S. L., Kesharwani, P., Jamialahmadi, T., & Sahebkar, A. (2023) · IUBMB Life · doi:10.1002/iub.2719 · Cited by 4
Karabörk, Ş., Çelik, H., Dursun, A. D., Ankaralı, H. Ç., & Türkoğlu, Ş. A. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_58 · Cited by 3
Dhiman, P., Singh, S., Arora, S., Sharma, N., Gulia, R., & Kishore, L. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010310578240926051158 · Cited by 3
Giacosa, A., Barrile, G. C., Gasparri, C., Perna, S., & Rondanelli, M. (2025) · Nutrients · doi:10.3390/nu17040723 · Cited by 3
Hashemian, S. M., Jafari, A., Khoundabi, B., Jamaati, H., & Rahimi, P. (2025) · Health Science Reports · doi:10.1002/hsr2.70571 · Cited by 3
Torres, W., Morillo, V., Manzano, A., Suarez, M., Parra, H., Lameda, V., Nava, M. D., D’Marco, L., Puchades, M. A., Medina, O., et al. (2021) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0973 · Cited by 3
The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets
Sun, C., Zhao, H., Han, Y., Wang, Y., & Sun, X. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0061 · Cited by 3
Silva‐Ramos, C. R., Mejorano‐Fonseca, J. A., Rodriguez-Morales, A. J., Hidalgo, M., & Faccini‐Martínez, Á. A. (2023) · Infezioni in Medicina · doi:10.53854/liim-3102-3 · Cited by 3
Impact and management of COVID-19 in liver transplant candidates and recipients
Liava, C. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0815 · Cited by 3
Giral-Barajas, J., Herrera-Nolasco, C. I., Herrera-Valdez, M. A., & López, S. I. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111576 · Cited by 3
Evaluating the long-term biological stability of cytokine biomarkers in ocular fluid samples
Felfeli, T., Park, J., Nestor, B., Altomare, F., Rai, A. S., Mandelcorn, E. D., Chow, D. R., & Wong, D. T. (2023) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2023-001346 · Cited by 3
Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity
Guzmán-Martínez, O., Guardado, K., Cardoso, M. V., Trujillo-Rivera, A., Gómez-Ñañez, I., León, M. C. O., Espinosa, R., Ramos, C., Pérez‐Carreón, J. I., López-Guerrero, D. V., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18179058 · Cited by 2
Gambaran Netrofil Pada Pasien Covid-19 Di Rumah Sakit Siloam Bogor
Permana, A., Nugroho, H. P., & Dewi, M. R. K. (2021) · Anakes Jurnal Ilmiah Analis Kesehatan · doi:10.37012/anakes.v7i2.695 · Cited by 3
Immunological insights of selectins in human disease mechanism
Selvaraj, C., Abhirami, R., Vijayakumar, R., Alfaiz, F. A., & Singh, S. K. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.11.005 · Cited by 3
Polyarthritis associated with COVID-19 (clinical case)
Aronova, E. S., & Belov, B. S. (2021) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2021-5-76-79 · Cited by 4
Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses
Mihăescu, G., Chifiriuc, M. C., Vrâncianu, C. O., Constantin, M., Filip, R., Popescu, M. R., Burlibaşa, L., Nicoară, A. C., Bolocan, A., Iliescu, C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9122578 · Cited by 3
SARS-CoV-2 Viroporins: A Multi-Omics Insight from Nucleotides to Amino Acids
Sarkar, M., Etheimer, P., Hannothiaux, V., & Saha, S. (2022) · Applied Microbiology · doi:10.3390/applmicrobiol2030045 · Cited by 3
Koçyiğit, A., Güler, E. M., İrban, A., Kıran, B., & Atayoğlu, A. T. (2022) · Journal of Integrative and Complementary Medicine · doi:10.1089/jicm.2022.0554 · Cited by 3
Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
Aguilar-Jiménez, W., Flórez‐Álvarez, L., Rincón, D. S., Marín-Palma, D., Sánchez-Martínez, A., Martínez-Moreno, J., Zapata-Cardona, M. I., Loaiza, J. D., Cárdenas, C., Guzmán, F., et al. (2021) · Biomédica · doi:10.7705/biomedica.5976 · Cited by 3
WITHDRAWNPreprint
Datta, S. (2021) · ChemRxiv · doi:10.26434/chemrxiv.13102877.v21 · Cited by 3
Untangling the cell immune response dynamic for severe and critical cases of SARS-CoV-2 infectionPreprint
Blanco‐Rodríguez, R., Du, X., & Hernandez-Vargas, E. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.23.436686 · Cited by 3
Dembić, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00090-2 · Cited by 3
Oktiansyah, R., Elfita, E., Wıdjajantı, H., Salni, S., & Setiawan, A. (2023) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d241213 · Cited by 2
Incidence Of Acute Kidney Injury In Mild, Moderate And Severe Cases Of Coronavirus Disease
Mahmud, M., Kumar, A., & Baqai, K. (2023) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v27i4.2304 · Cited by 2
Hultgren, N. W., Petcherski, A., Torriano, S., Komirisetty, R., Sharma, M. B., Zhou, T., Burgess, B. L., Ngo, J., Osto, C. A., Shabane, B., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae500 · Cited by 2
Immunity's core reset: Synbiotics and gut microbiota in the COVID-19 era
Bajić, D., Todorović, N., Popović, M. L., Plazačić, M., & Mihajlović, A. (2025) · Innate Immunity · doi:10.1177/17534259251362023 · Cited by 2
Identification of hub genes associated with severe COPD via WGCNA and immune infiltration analysis
Zhao, L., Liang, Y. F., Yang, W., Yang, X. N., Peng, H.-J., Wang, Y., Li, Y., & Zhang, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-18602-w · Cited by 2
A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines
Ebrahimi, B., Jahromi, H. K., Nazanin, S. J., & Molayem, M. (2025) · Journal of Immunology Research · doi:10.1155/jimr/8766021 · Cited by 3
Immunological aspects of COVID-19: what we know so far
Mamun, K. Z., Mahboob, N., Mamun, K. T., Iqbal, H., & Afrin, S. (2021) · Bangladesh Journal of Medicine · doi:10.3329/bjm.v32i1.51094 · Cited by 2
Sharma, S., & Maheshwari, S. (2021) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/1170/1/012003 · Cited by 2
The Potential Impact of Ayurvedic Traditional Bhasma on SARS-CoV- 2- Induced Pathogenesis
Kumar, P., Jayakumar, R., Dash, M. K., & Joshi, N. (2022) · Current Traditional Medicine · doi:10.2174/2215083808666220321145803 · Cited by 2
Post-Infectious Arthritis and Reactive Arthritis
Ferreira, Á., Marinho, A., Vita, P., Fonseca, T., & Vasconcelos, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99130-8.00047-7 · Cited by 2
Choi, Y., Yang, J.-M., Jeong, C.-W., Yoo, H.-W., Jo, H.-D., & Cho, J. (2024) · Journal of Food Hygiene and Safety · doi:10.13103/jfhs.2024.39.1.44 · Cited by 2
Light-Based Therapy: Novel Approach to Treat COVID-19.
Azadeh, S. S., Djavid, G. E., Nobari, S., Neghab, H. K., & Rezvan, M. (2023) · PubMed Central · Cited by 2
Wang, Y., Tao, X., & Jin, P. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s465805 · Cited by 3
Effect of Aspirin Use on the Adverse Outcomes in Patients Hospitalized for COVID-19
Vinod, P., Krishnappa, V., Rathell, W., Amir, S., Sundil, S., Dogbey, G. Y., Patel, H. D., & Herzog, W. (2024) · Cardiology Research · doi:10.14740/cr1645 · Cited by 2
El-Deeb, N. A., Andargeery, S. Y., Nofal, H. A. E., Elrafey, D. S., Mohamed, E., Ibrahim, N. F., Ali, H. T., & Sadek, A. M. E. M. (2024) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2024.102523 · Cited by 2
Wang, C., Damiano, R. J., Ruebush, L. E., ENGELEN, M. P. K. J., Mariani, S., Liu, L., Silva, I., Borhani, S., Coté, G. L., Conroy, B., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126292 · Cited by 2
Taha, A. M., Elrosasy, A., Mohamed, A. S., Mohamed, A. E., Bani-Salameh, A., Siddiq, A., Cadri, S., Elshahat, A., Abdelmonteser, A. A., & Abouelmagd, M. E. (2024) · Cureus · doi:10.7759/cureus.70613 · Cited by 2
Avhaitis, S. S., & Сидь, Е. В. (2024) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2024-28(3)-28 · Cited by 2
HLA-DR4Pred2: An improved method for predicting HLA-DRB1*04:01 binders
Patiyal, S., Dhall, A., Kumar, N., & Raghava, G. P. S. (2024) · Methods · doi:10.1016/j.ymeth.2024.10.007 · Cited by 2
Outcomes of COVID-19 in Pregnant Women: A Retrospective Analysis of 300 Cases in Jordan
Al-Amoosh, H., Al-Amer, R. M., Alamoush, A. H., Alquran, F., Aldajeh, T. M. A., Rahamneh, T. A. A., Gharaibeh, A., Ali, A. M., Maaita, M., & Darwish, T. (2024) · Healthcare · doi:10.3390/healthcare12212113 · Cited by 2
Zhu, Y., Lai, Y. K., Xie, Q., Wang, J. Z., You, F., & Zhao, X. (2025) · Health Communication · doi:10.1080/10410236.2025.2526020 · Cited by 3
Post-COVID-19 insomnia beyond stress: insights from polysomnography
Yang, J., Yang, Y., & Xu, Y. (2025) · SLEEP · doi:10.1093/sleep/zsaf336 · Cited by 2
A case report of COVID-19 in a patient with non-Hodgkin’s lymphoma
Eilami, O., Lopes, M. I. B. F., Gryschek, R. C. B., & Taghipour, K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06472-2 · Cited by 2
ALTERAÇÕES HEMATOLÓGICAS DA COVID-19
de Paula, H. I., Amorim, D. L. A. N., Gonzaga, G. M., Batista, J. S., Ferreira, F. S. B., & Xavier, F. D. (2021) · Brasília Médica · doi:10.5935/2236-5117.2021v58a70 · Cited by 2
Dynamics of level of class G antibodies to SARS-CoV-2 after new coronavirus infection COVID-19
Aleksanin, S. S., Александровна, А. Н., Алексеевна, К. Н., & Rybnikov, V. Y. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-30-7-11 · Cited by 2
Raposo, L. M., Abreu, G. F. D., Cardoso, F. B. D. M., Alves, A. T. J., Rosa, P. T. C. R., & Nobre, F. F. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.04.013 · Cited by 2
GÜVEN, B. B., Özçelik, F., & Tanoğlu, A. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.115091 · Cited by 2
Cardiac manifestation of corona virus disease 2019: a preliminary report
Lasisi, G., Duro-Emanuel, A., Akintomide, T., Ologunja, J. O., & Amah, O. (2021) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2020-061 · Cited by 2
McAlpine, L. S., Barden, M. M., Zubair, A. S., & Sanamandra, S. (2021) · Cureus · doi:10.7759/cureus.13277 · Cited by 2
Aliyu, M., Mozhgani, S., Gargari, O. K., Yusuf, M. A., & Saboor-Yaraghi, A. A. (2021) · AIMS Allergy and Immunology · doi:10.3934/allergy.2021018 · Cited by 2
Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients
Amrani, F. A., Al-Abdwani, R., Rashdi, F. A., Al‐Ajmi, E., & Al-Futaisi, A. M. (2022) · Sultan Qaboos University medical journal · doi:10.18295/squmj.5.2022.040 · Cited by 2
Deng, X., Zhang, Y., Li, M., Tang, X., Chen, Y., Chen, Y., Zhao, Y., Wen, Q., Wu, X., Li, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71163 · Cited by 2
Bhattacharya, M., Sharma, A. R., Mallick, B., Lee, S., Seo, E.-M., & Chakraborty, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.895695 · Cited by 2
Morovati, H., Eslami, S., Bonab, H. F., Kord, M., & Darabian, S. (2022) · Iranian Journal of Microbiology · doi:10.18502/ijm.v14i5.10955 · Cited by 2
COVID-19 in childhood and phenotypes of pediatric inflammatory multisystem syndrome
Sergi, C. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85389-7.00013-2 · Cited by 2
Kumari, A., Ranjan, A., Nishant, P., Sinha, S., & Sinha, R. K. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2507_22 · Cited by 2
Relación clínica entre la artritis reactiva y la infección por SARS-CoV-2: una revisión exploratoria
Tuta-Quintero, E., Santacruz, J. C., Camacho, J., Olivella, J., Collazos, E., Gómez, J. C., Ochoa, D. A., Salazar-Villa, J., Rodríguez, J. E., Pérez, D. F., et al. (2023) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2023.04.001 · Cited by 2
Vollrath, S., Matits, L., Jerg, A., Zorn, J., John, L., Steinacker, J. M., & Bizjak, D. A. (2023) · Biomedicines · doi:10.3390/biomedicines11071911 · Cited by 2
Cao, Y., Han, Y., Wu, J., Sun, J., Dai, Y., Qiao, G., Li, K., Li, A., Zhang, Y., Ma, Y., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s432679 · Cited by 3
A Review on Role of Inflammation in Coronavirus Disease
Lotfi, A., Hajian, P., Abbasi, L., Gargari, M. K., Fard, N. N. G., & Naderi, D. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303265274231204075802 · Cited by 2
Mehta, S. A., & Prabhudesai, P. (2020) · Cureus · doi:10.7759/cureus.11512 · Cited by 2
Peculiarities of community acquired pneumonia triggered by novel coronavirus SARS-CoV-2 (review)
Анатольевна, Б. Е., & Trotsenko, O. E. (2020) · Bulletin physiology and pathology of respiration · doi:10.36604/1998-5029-2020-78-135-146 · Cited by 2
Baruah, A., Kalita, M. K., Khuman, L. S., Boruah, K., Gogoi, A., Bordoloi, G., & Khargharia, S. (2021) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.covid19.2021.10.2.8 · Cited by 2
JAK Inhibitors as a Barrier to the Destructive Cytokine Storm in COVID-19
Saeedi‐Boroujeni, A., & Asadi-Samani, M. (2022) · Current Drug Research Reviews · doi:10.2174/2589977514666220304203816 · Cited by 2
Metadata
- Authors
- García, L. F.
- Affiliations
- Universidad de Antioquia (CO)
- Corresponding author
- García, Luis F.
- ORCID
- García, Luis F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-16
- Volume
- 11
- Pages
- 1441-1441
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7308593
- OpenAlex
- W3035895802
- Cited by
- 739
- References
- 141
- Citations by year
- 2026: 17 · 2025: 30 · 2024: 68 · 2023: 89 · 2022: 172 · 2021: 279 · 2020: 83
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, immune response, inflammation, clinical spectrum, immunopathogenesis, disease severity, SARS, MERS, immune regulation, coronavirus infection
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Age Factors, Antibodies, Viral, Humans, Immunoglobulin A, Secretory, Inflammation, Macrophages, Pneumonia, Viral, T-Lymphocytes, Cytokines, Coronavirus Infections, Antibody-Dependent Enhancement, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
